Fever and rash in children
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ifeoma Anaya, M.D.[2]
Synonyms and keywords: Fever and rash in kids
Overview
Fever and skin rash are very common symptoms seen in pediatric populations both in clinic and hospital settings. Disease states associated with these symptoms are varied and can range from benign to extremely severe illness requiring prompt intervention in the emergency room or even ICU. Therefore, a vast knowledge of these disease states is very important as oftentimes, diagnosis is mainly clinical.
Historical Perspective
- [Disease name] was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
- In [year], [gene] mutations were first identified in the pathogenesis of [disease name].
- In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name].
Classification
Febrile rashes can be classified based on morphology (maculopapular, pustular, vesicular, etc); based on distribution of spread (systemic and localized); based on pattern of occurrence (acute and chronic); based on the cause (infectious and non-infectious) [1].
Common types of rashes encountered in clinical practice [1]:
| Type of Rash/Lesion | Description |
|---|---|
| Macule | flat, circumscribed, usually <1cm in diameter |
| Papule | raised/elevated lesion <1cm in diameter |
| Maculopapular | combination of both macules and papulus |
| Nodule | papule in deeper dermis or subcutaneous tissue |
| Pustule | circumscribed raised lesion containing purulent material |
| Vesicle | circumscribed elevated skin lesion usually <1cm containing fluid |
| Bulla | Bigger vesicle (>1cm and containing fluid) |
| Petechiae | non-blanching pinpoint unraised spots usually measuring <2mm in size |
| Purpura | non-blanching papules or macules due to extravasation of RBCs. Vary between 2mm-1cm in size |
| Ecchymoses | non-blanching lesions usually measuring larger than 1cm |
Classification of febrille rashes [2] [3] [4] [5]:
| Fever + Rash Morphology | Disease |
|---|---|
| Non-blanching lesions (Petechiae, Purpura and Ecchymoses) | a. Meningococcemia
b. Rocky Mountain Spotted Fever (RMSF) c. Hemolytic Uremic Syndrome (HUS) d. Henoch-Schőnlein Purpura (HSP) |
| Blanching rash | a. Kawasaki disease
b. Juvenile Rheumatoid Arthritis c. Juvenile Dermatomyositis |
| Vesicular or bullous lesions | a. Erythema multiforme
b. Steven-Johnson-Syndrome (SJS) and Toxic Epridermal Necrolysis (TEN) c. Staphylococcal Scalded Skin Syndrome (SSSS) d. Disseminated gonococcal disease in adolescents e. HSV I & II |
| Umbilicated papules and pustules | a. Molluscum contagiosum
b. Varicella/Chickenpox |
| Sandpaper rash | a. Scarlet fever |
| Viral syndromes | a. Measles (Rubeola)
b. Rubella (German measles) c. Erythema infectiosum (Parvovirus B-19) d. Herpangina (Coxsackie) e. Hand-foot-and-mouth disease (Coxsackie) f. Roseola infantum (Human Herpes Virus types 6 or 7) |
| Limited to certain geographical areas | a. Babesiosis
b. Blastomycosis c. Coccidiodomycosis d. Histoplasmosis e. Colorado Tick Fever f. Lyme disease g. Relapsing fever h. Colorado Tick Fever |
Pathophysiology
- The pathogenesis of [disease name] is characterized by [feature1], [feature2], and [feature3].
- The [gene name] gene/Mutation in [gene name] has been associated with the development of [disease name], involving the [molecular pathway] pathway.
- On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
- On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
Causes
| Infectious | Disease | Causative Organism | Non-Infectious | Disease |
|---|---|---|---|---|
| Viral | Measles
German Measles Erythema infectiosum Roseola infantum Herpangina Hand-foot-and-mouth disease Molluscum contagiosum Chickenpox |
Rubeola
Rubella Parvovirus B19 Human Herpes Virus 6 & 7 Coxsackie virus Coxsackie virus Poxvirus Varicella Zoster virus |
Vasculitis | Kawasaki Disease
Henoch-Schőnlein Purpura Juvenile Rheumatoid Athritis Juvenile Dermatomyositis |
| Bacterial | Meningococcemia |
Neisseria meningitidis
Hemophilus influenzae Streptococcus pneumoniae
|
Adverse drug reactions | Erythema multiforme
SJS TEN |
| RMSF | Rickettsia rickettsii | |||
| HUS | Enterohemorrhagic E.coli (EHEC) | |||
| Scarlet Fever | Streptococcus pyogenes (Group A Streptococci, GAS) | |||
| Disseminated gonococcal disease in adolescents | Neiserria gonorrhoea | |||
| SSSS
TSS |
Staphylococcus aureus | |||
| Lyme disease | Borrelia burgdorferi | |||
| Relapsing fever | Borrelia recurrentis | |||
| Protozoan | Babesiosis | Babesia microti | ||
| Fungal | Histoplasmosis
Blastomycosis Coccidiodomycosis Paracoccidiodomycosis |
Histoplasma capsulatum
Blastomyces dermatitidis Coccidioides immitis Paracoccidioides brasiliensis |
Differentiating [disease name] from other Diseases
For further information about the differential diagnosis, click here.
Epidemiology and Demographics
- The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide.
- In [year], the incidence of [disease name] was estimated to be [number or range] cases per 100,000 individuals in [location].
Age
- Patients of all age groups may develop [disease name].
- [Disease name] is more commonly observed among patients aged [age range] years old.
- [Disease name] is more commonly observed among [elderly patients/young patients/children].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected with [disease name] than [gender 2].
- The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.
Race
- There is no racial predilection for [disease name].
- [Disease name] usually affects individuals of the [race 1] race.
- [Race 2] individuals are less likely to develop [disease name].
Risk Factors
- Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
Natural History, Complications and Prognosis
- The majority of patients with [disease name] remain asymptomatic for [duration/years].
- Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
- If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
- Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
- Prognosis is generally [excellent/good/poor], and the [1/5/10year mortality/survival rate] of patients with [disease name] is approximately [#%].
Diagnosis
Diagnostic Criteria
- The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met:
- [criterion 1]
- [criterion 2]
- [criterion 3]
- [criterion 4]
Symptoms
- [Disease name] is usually asymptomatic.
- Symptoms of [disease name] may include the following:
- [symptom 1]
- [symptom 2]
- [symptom 3]
- [symptom 4]
- [symptom 5]
- [symptom 6]
Physical Examination
- Patients with [disease name] usually appear [general appearance].
- Physical examination may be remarkable for:
- [finding 1]
- [finding 2]
- [finding 3]
- [finding 4]
- [finding 5]
- [finding 6]
Laboratory Findings
- There are no specific laboratory findings associated with [disease name].
- A [positive/negative] [test name] is diagnostic of [disease name].
- An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
- Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
Electrocardiogram
There are no ECG findings associated with [disease name].
OR
An ECG may be helpful in the diagnosis of [disease name]. Findings on an ECG suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
X-ray
There are no x-ray findings associated with [disease name].
OR
An x-ray may be helpful in the diagnosis of [disease name]. Findings on an x-ray suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
There are no x-ray findings associated with [disease name]. However, an x-ray may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
Echocardiography or Ultrasound
There are no echocardiography/ultrasound findings associated with [disease name].
OR
Echocardiography/ultrasound may be helpful in the diagnosis of [disease name]. Findings on an echocardiography/ultrasound suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
There are no echocardiography/ultrasound findings associated with [disease name]. However, an echocardiography/ultrasound may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
CT scan
There are no CT scan findings associated with [disease name].
OR
[Location] CT scan may be helpful in the diagnosis of [disease name]. Findings on CT scan suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
There are no CT scan findings associated with [disease name]. However, a CT scan may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
MRI
There are no MRI findings associated with [disease name].
OR
[Location] MRI may be helpful in the diagnosis of [disease name]. Findings on MRI suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
There are no MRI findings associated with [disease name]. However, a MRI may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
Other Imaging Findings
There are no other imaging findings associated with [disease name].
OR
[Imaging modality] may be helpful in the diagnosis of [disease name]. Findings on an [imaging modality] suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
Other Diagnostic Studies
- [Disease name] may also be diagnosed using [diagnostic study name].
- Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].
Treatment
Medical Therapy
- There is no treatment for [disease name]; the mainstay of therapy is supportive care.
- The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
- [Medical therapy 1] acts by [mechanism of action 1].
- Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].
Surgery
- Surgery is the mainstay of therapy for [disease name].
- [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
- [Surgical procedure] can only be performed for patients with [disease stage] [disease name].
Prevention
- There are no primary preventive measures available for [disease name].
- Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
- Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].
References
- ↑ 1.0 1.1 Kang JH (2015). "Febrile Illness with Skin Rashes". Infect Chemother. 47 (3): 155–66. doi:10.3947/ic.2015.47.3.155. PMC 4607768. PMID 26483989.
- ↑ https://www.consultant360.com/articles/rashes-and-fever-children-sorting-out-potentially-dangerous-part-1
- ↑ https://www.consultant360.com/articles/rashes-and-fever-children-sorting-out-potentially-dangerous-part-2
- ↑ https://www.consultant360.com/articles/rashes-and-fever-children-sorting-out-potentially-dangerous-part-3
- ↑ https://www.consultant360.com/articles/rashes-and-fever-children-sorting-out-potentially-dangerous-part-4